Table 1.
N (%) or mean ± SD or median (Q1–Q3) | Reference data from controls or standard ranges | |
---|---|---|
SLE patients, n = 51 | ||
Female | 47 (92%) | 39 (76%); p=0.06 |
Age (years) | 48.8 ± 14.3 | 44.9 ± 11.1; p=0.12 |
Disease duration (months) | 50 (24.5–148) | |
Members of SLEx registry | 31 (61%) | |
NPSLE | 4 (8%) | |
BMI (kg/m2) | 29 (6.5) | 20–25 normal, 25–30 overweight, 30–35 obese, 35+ clinically obese |
Current smoker | 6 (12%) | |
Hypertension | 9 (18%) | ≥140/90 mm Hg |
Fatigue (score) | 5.0 ± 1.7 | 2.3 ± 0.7; p<0.0001 |
Anxiety (score) | 6 (3–12) | 0–7 non-case, 8–10 borderline, 11+ case |
Depression (score) | 8 (6–12) | As anxiety |
Current steroids | 18 (35%) | |
MoCA (score) (n=50) | 26 (24–28) | 0–30. Normal ≥26 |
ACER (score) (n=50) | 91 (87–94) | 0–100. Normal ≥88 |
MMSE (score) (n=50) | 28 (27–30) | 0–30. Normal ≥27 |
NART (score) (n=50) | 34 (27–39) | 40 (34–42); p=0.0008 |
ACER = Addenbrooke’s Cognitive Examination – Revised, BMI = body mass index, MoCA = Montreal Cognitive Assessment, MMSE = Mini Mental State Examination, NART = National Adult Reading Test